CDC approves Moderna, Pfizer-BioNTech Omicron booster shots for everyone 12 and older

-
BlogOn September 5, the Centers for Disease Control and Prevention endorsed the Advisory Committee on Immunization Practices’ recommendation for updated COVID-19 boosters for everyone age 12 and up, following the Food and Drug Administration’s approval of an emergency use authorization for the updated Pfizer-BioNTech and Moderna boosters on August 31.CDC approves Moderna, Pfizer-BioNTech Omicron booster shots for everyone 12 and older
-
Blog
CDC approves Moderna, Pfizer-BioNTech Omicron booster shots for everyone 12 and older
On September 5, the Centers for Disease Control and Prevention (CDC) endorsed the Advisory Committee on Immunization Practices’ (ACIP) recommendation for updated COVID-19 boosters for everyone age 12 and up, following the Food and Drug Administration’s (FDA) approval of an emergency use authorization for the updated Pfizer-BioNTech and Moderna boosters on August 31. The boosters generate stronger immune protection against COVID-19 variants that are currently circulating widely in the U.S.
The updated emergency use authorizations permit the administration of a single booster at least two months after a primary or booster dose is given. The CDC Director, Dr. Rochelle Walensky, released a statement recommending eligibility for the Pfizer-BioNTech bivalent COVID-19 booster for people ages 12 and older and the Moderna COVID-19 booster for people ages 18 and older. The updated COVID-19 boosters add protection against the Omicron BA.4 and BA.5 variants, which currently make up nearly 90 percent of all cases of COVID-19 in the U.S. The CDC booster recommendation is for all individuals that have received at least a full primary vaccination series, which according to CDC guidance includes both a primary (2-dose) series and a one-dose booster.
The Biden administration has ordered 175 million doses of the new boosters. Pfizer plans to ship up to 15 million doses of its booster to the U.S. by September 9. Additionally, Pfizer plans to apply for an emergency use authorization for its booster to be used for children ages 5-11 in early October and is working to receive FDA approval for boosters for children under the age of 5.
The COVID-19 vaccines authorized for use in the U.S. continue to reduce the risk of severe disease, hospitalization and death, including against the Omicron variant and subvariants. As key providers of local public health services and frontline service providers for the medically vulnerable, counties have supported the administration of more than 610 million vaccinations in the United States to date and will continue to play an essential role in the administration of COVID-19 vaccines and boosters.
ADDITIONAL RESOURCES
- CDC COVID-19 booster tool
- The County Role in Vaccines
- CDC Approves COVID-19 Vaccine for Children under 5
On September 5, the Centers for Disease Control and Prevention endorsed the Advisory Committee on Immunization Practices’ recommendation for updated COVID-19 boosters for everyone age 12 and up, following the Food and Drug Administration’s approval of an emergency use authorization for the updated Pfizer-BioNTech and Moderna boosters on August 31.2022-09-08Blog2022-09-08
On September 5, the Centers for Disease Control and Prevention (CDC) endorsed the Advisory Committee on Immunization Practices’ (ACIP) recommendation for updated COVID-19 boosters for everyone age 12 and up, following the Food and Drug Administration’s (FDA) approval of an emergency use authorization for the updated Pfizer-BioNTech and Moderna boosters on August 31. The boosters generate stronger immune protection against COVID-19 variants that are currently circulating widely in the U.S.
The updated emergency use authorizations permit the administration of a single booster at least two months after a primary or booster dose is given. The CDC Director, Dr. Rochelle Walensky, released a statement recommending eligibility for the Pfizer-BioNTech bivalent COVID-19 booster for people ages 12 and older and the Moderna COVID-19 booster for people ages 18 and older. The updated COVID-19 boosters add protection against the Omicron BA.4 and BA.5 variants, which currently make up nearly 90 percent of all cases of COVID-19 in the U.S. The CDC booster recommendation is for all individuals that have received at least a full primary vaccination series, which according to CDC guidance includes both a primary (2-dose) series and a one-dose booster.
The Biden administration has ordered 175 million doses of the new boosters. Pfizer plans to ship up to 15 million doses of its booster to the U.S. by September 9. Additionally, Pfizer plans to apply for an emergency use authorization for its booster to be used for children ages 5-11 in early October and is working to receive FDA approval for boosters for children under the age of 5.
The COVID-19 vaccines authorized for use in the U.S. continue to reduce the risk of severe disease, hospitalization and death, including against the Omicron variant and subvariants. As key providers of local public health services and frontline service providers for the medically vulnerable, counties have supported the administration of more than 610 million vaccinations in the United States to date and will continue to play an essential role in the administration of COVID-19 vaccines and boosters.
ADDITIONAL RESOURCES

About Blaire Bryant (Full Bio)
Legislative Director – Health | Large Urban County Caucus
More from Blaire Bryant
-
Blog
Senate HELP Committee seeks comments on pandemic and all-hazards preparedness
On March 15, Chairman Bernie Sanders (I-Vt.) and Ranking Member Bill Cassidy (R-La.) of the U.S. Senate Health, Education, Labor and Pensions Committee (HELP) released a request for information seeking input from public health officials, health care providers and other stakeholders on policies the Committee should consider during the reauthorization of the Pandemic and All-Hazards Preparedness Act. -
Blog
NACo submits comments to Senate HELP Committee on health care workforce shortages
On March 2, the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP) Committee released a request for information from health care stakeholders on the causes of and solutions for current health care workforce shortages. -
Blog
County officials discuss harm reduction as a path forward through the overdose epidemic
Dr. Gregory Wm. Branch, director of the Baltimore County, Md. Department of Health and Human Services, speaks at NACo’s 2023 Legislative Conference. Photo by Leon Lawrence III. -
Blog
Addressing social determinants of health with GIS technology
Discover the transformative power of GIS technology in addressing social determinants of health and building healthier communities. -
Blog
New CDC data reveals rates of poor mental health and suicidality on the rise for youth in the U.S.
The Centers for Disease Control and Prevention released the Youth Risk Behavior Survey Data Summary & Trends Report: 2011-2019, which provides data on health-related behaviors that contribute to the leading causes of death amongst youth and adults. -
Blog
HHS releases guidance on the end of the COVID-19 Public Health Emergency
On February 9, the U.S. Department of Health and Human Services released new guidance on the agency’s plan to end the federal COVID-19 Public Health Emergency declaration on May 11, 2023.
-
Webinar
County Leaders Championing Justice Efforts in Local Communities
April 5, 2023 , 2:00 pm – 3:00 pmCounties are directing resources to programs, practices and policies to reduce the overuse and misuse of the criminal legal system, improve public safety, better serve residents with behavioral health conditions and improve community stability and health.04052:00 pm<p>Counties are directing resources to programs, practices and policies to reduce the overuse and misuse of the criminal legal system, improve public safety, better serve residents with behavioral health conditions and improve communit
-
Webinar
Strategies for Leveraging County Health Rankings Data to Improve Community Health
April 19, 2023 , 2:00 pm – 3:00 pmCounties play a key role in public health at the local level, as the conveners of multi-sector stakeholders, administrators of federal health-funding programs, like Medicaid, and providers of many crucial health services for residents.04192:00 pm<p>Counties play a key role in public health at the local level, as the conveners of multi-sector stakeholders, administrators of federal health-funding programs, like Medicaid, and providers of many crucial health services for residen
-
Basic page
The Stepping Up Initiative
In May 2015, NACo and partners at the CSG Justice Center and APA Foundation launched Stepping Up: A National Initiative to Reduce the Number of People with Mental Illnesses in Jails.pagepagepage<table border="1" cellpadding="1" cellspacing="1" style="width:100%" summary="call-out">
<tbody>
<tr>
<td> -
Reports & Toolkits
COVID-19 Recovery Clearinghouse
The COVID-19 Recovery Clearinghouse features timely resources for counties, including allocation estimations, examples of county programs using federal coronavirus relief funds, the latest news and more.Reports & Toolkitsdocument03127:15 pmReports & Toolkits<table border="1" cellpadding="1" cellspacing="1" style="width:100%" summary="ad-block no-top-margin no-bullets">
<caption>Jump to Section</caption> -
Basic page
Live Healthy U.S. Counties
The National Association of Counties (NACo) Live Healthy Prescription, Health & Dental Discount Program is a NO-COST program available to all member counties.pagepagepage<h1>With <a id="naco" name="naco">NACo</a>, Saving Feels Better</h1>
-
Reports & Toolkits
Opioid Solutions Center
NACo’s Opioid Solutions Center empowers local leaders to invest resources in effective treatment, recovery, prevention and harm reduction practices that save lives and address the underlying causes of substance use disorder.Reports & Toolkitsdocument10123:30 pmReports & Toolkits<p>NACo's Opioid Solutions Center empowers local leaders to invest resources in effective treatment, recovery, prevention and harm reduction practices that save lives and address the underlying causes of substance use disorder.
Contact
-
Legislative Director – Health | Large Urban County Caucus(202) 942-4246
-
Legislative Assistant(202) 942-4259
Related Posts
-
BlogNACo submits comments to Senate HELP Committee on health care workforce shortagesMar. 23, 2023
-
BlogSenate HELP Committee seeks comments on pandemic and all-hazards preparednessMar. 23, 2023
-
BlogCounty officials discuss harm reduction as a path forward through the overdose epidemicMar. 21, 2023
Related Resources
-
DocumentThe Principles Quick Guide to Conducting a Needs AssessmentFeb. 27, 2023
-
Reports & ToolkitsThe County Role In Long-Term CareFeb. 24, 2023
-
Reports & ToolkitsLegislative Analysis for Counties: The Inflation Reduction ActFeb. 22, 2023
Related Events
-
5Apr2023Webinar
County Leaders Championing Justice Efforts in Local Communities
Apr. 5, 2023 , 2:00 pm – 3:00 pm -
19Apr2023Webinar
Strategies for Leveraging County Health Rankings Data to Improve Community Health
Apr. 19, 2023 , 2:00 pm – 3:00 pm
More From
-
NACo Summit on Mental Health Solutions
Congressional, federal agency leaders and national thought leaders will gather with county officials to discuss priorities for curbing the ongoing mental health crisis.
Learn More